Sesen Bio, Inc. (SESN)

USD 0.63

(7.29%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue 40 Million 26.54 Million 11.23 Million - - 425 Thousand
Cost of Revenue - - - - - -
Gross Profit 40 Million 26.54 Million 11.23 Million - - 425 Thousand
Operating Expenses 78.38 Million 54.7 Million 43.49 Million 36.87 Million 25.7 Million 20.58 Million
Selling, General and Administrative Expenses 39.78 Million 29.39 Million 14.3 Million 12.2 Million 11.62 Million 8.07 Million
Research and Development Expenses 38.59 Million 25.31 Million 29.19 Million 24.66 Million 14.07 Million 12.51 Million
Other Expenses 296 Thousand -60 Thousand 125 Thousand 991 Thousand 807 Thousand 226 Thousand
Cost and Expenses 78.38 Million 54.7 Million 43.49 Million 36.87 Million 25.7 Million 20.58 Million
Operating Income -25.9 Million -8.54 Million -21.07 Million 34.74 Million -34.5 Million -29.25 Million
Interest Expense - - - - - -
Income Tax Expense -3.87 Million -8.27 Million 1.44 Million 71.62 Million 807 Thousand 226 Thousand
Earnings before Tax -23.75 Million -8.6 Million -20.95 Million -107.5 Million -33.69 Million -29.02 Million
Net Income -19.88 Million -336 Thousand -22.39 Million -179.12 Million -34.5 Million -29.02 Million
Earnings Per Share Basic -1.99 -0.04 -3.79 -39.40 -11.17 -22.24
Earnings Per Share Diluted -1.99 -0.04 -3.79 -39.40 -11.17 -22.24
Weighted Average Shares Outstanding 9.97 Million 9.11 Million 5.91 Million 4.54 Million 3.08 Million 1.3 Million
Weighted Average Shares Outstanding (Diluted) 9.97 Million 9.11 Million 5.91 Million 4.54 Million 3.08 Million 1.3 Million
Gross Margin 1.00 1.00 1.00 - - 1.00
EBIT Margin -1.27 -1.80 -3.86 - - -46.22
Profit Margin -0.50 -0.01 -1.99 - - -68.30
EBITDA -50.84 Million -8.54 Million -21.07 Million 34.96 Million -24.68 Million -19.64 Million
Earnings Before Tax Margin -0.65 -0.32 -1.88 - - -68.84

Income Statement Charts